Initial Longitudinal Outcomes of Risk-Stratified Men in Their Forties Screened for Prostate Cancer Following Implementation of a Baseline Prostate-Specific Antigen-Reference-Cited by-同舟云学术

Initial Longitudinal Outcomes of Risk-Stratified Men in Their Forties Screened for Prostate Cancer Following Implementation of a Baseline Prostate-Specific Antigen

Published:2022 Issue: Volume:40 Page:
ISSN:2287-4208
Container-title:The World Journal of Men's Health
language:en
Short-container-title:World J Mens Health

Author:

Michael Zoe D.¹²^ORCID,Kotamarti Srinath¹²^ORCID,Arcot Rohith¹²^ORCID,Morris Kostantinos¹²^ORCID,Shah Anand¹³^ORCID,Anderson John¹⁴^ORCID,Armstrong Andrew J.¹³^ORCID,Gupta Rajan T.¹⁵^ORCID,Patierno Steven¹³⁴^ORCID,Barrett Nadine J.¹³^ORCID,George Daniel J.¹³^ORCID,Preminger Glenn M.¹²^ORCID,Moul Judd W.¹²^ORCID,Oeffinger Kevin C.¹³^ORCID,Shah Kevin¹³^ORCID,Polascik Thomas J.¹²^ORCID,

Affiliation:

1. The Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC, USA.

2. Division of Urologic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA.

3. Department of Medicine, Duke University Medical Center, Durham, NC, USA.

4. Department of Family Medicine and Community Health, Duke University Medical Center, Durham, NC, USA.

5. Department of Radiology, Duke University Medical Center, Durham, NC, USA.

Publisher

Korean Society for Sexual Medicine and Andrology

Subject

Pharmacology (medical),Urology,Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Health Policy,Aging,Reproductive Medicine

Link

https://wjmh.org/pdf/10.5534/wjmh.220068

Reference24 articles.

1. Serum Prostate-Specific Antigen in a Community-Based Population of Healthy Men

2. Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record

3. Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network

4. Initial Prostate Specific Antigen 1.5 ng/ml or Greater in Men 50 Years Old or Younger Predicts Higher Prostate Cancer Risk

5. Risk-Based Prostate Cancer Screening